Literature DB >> 8223060

Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis.

K P Nugent1, A D Spigelman, R K Phillips.   

Abstract

PURPOSE: Despite the introduction of screening, surveillance, and prophylactic colectomy surgery, patients with familial adenomatous polyposis (FAP) are at risk of dying from other malignancies.
METHODS: In order to quantify this risk and identify the causes of mortality, a retrospective life table analysis was performed on 222 patients with familial adenomatous polyposis who had undergone a total colectomy and ileorectal anastomosis between 1948 and 1990. These FAP patients were compared with an age- and sex-matched group of the general population and a relative risk of dying was calculated.
RESULTS: Of 222 patients, 53 have died. In a matched group of the general population the expected number of deaths would be 15.8. The relative risk of dying is therefore 3.35. There has been no significant improvement with time and the relative risk is greatest for female patients.
CONCLUSION: The three main causes of mortality are upper gastrointestinal malignancy, desmoid disease, and perioperative complications. Further research should therefore be aimed at prevention and improved treatment of these in order to improve survival.

Entities:  

Mesh:

Year:  1993        PMID: 8223060     DOI: 10.1007/bf02047300

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  51 in total

Review 1.  Chemoprevention in familial adenomatous polyposis.

Authors:  Brian Kim; Francis M Giardiello
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

2.  The management of colonic polyps in children: a 13-year retrospective study.

Authors:  Valeria Dipasquale; Claudio Romano; Mauro Iannelli; Andrea Tortora; Alessandro Princiotta; Marco Ventimiglia; Giuseppinella Melita; Socrate Pallio
Journal:  Eur J Pediatr       Date:  2021-03-16       Impact factor: 3.183

Review 3.  The current status of chemoprevention in FAP.

Authors:  M H Wallace; P M Lynch
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

4.  Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis.

Authors:  James R A Skipworth; Clare Morkane; Dimitri Aristotle Raptis; Soumil Vyas; Steven W Olde Damink; Charles J Imber; Stephen P Pereira; Massimo Malago; Nicholas West; Robin K S Phillips; Sue K Clark; Arjun Shankar
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

Review 5.  [Preventive surgery for familial adenomatous polyposis coli].

Authors:  M Kadmon
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

6.  Evaluating causes of death in familial adenomatous polyposis.

Authors:  Fábio Guilherme C M de Campos; Rodrigo Oliva Perez; Antônio Rocco Imperiale; Víctor Edmond Seid; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  J Gastrointest Surg       Date:  2010-07-30       Impact factor: 3.452

7.  The role of cell proliferation and crypt fission in adenoma aggressiveness: a comparison of ileoanal pouch and rectal adenomas in familial adenomatous polyposis.

Authors:  O C C Will; M Deheragoda; R K S Phillips; S K Clark; I P M Tomlinson
Journal:  Colorectal Dis       Date:  2011-04       Impact factor: 3.788

8.  Extracolonic manifestations of hereditary colorectal cancer syndromes.

Authors:  Daniel A Anaya; George J Chang; Miguel A Rodriguez-Bigas
Journal:  Clin Colon Rectal Surg       Date:  2008-11

9.  Long-term outcome of metachronous rectal cancer following ileorectal anastomosis for familial adenomatous polyposis.

Authors:  Tomohiro Yamaguchi; Seiichiro Yamamoto; Shin Fujita; Takayuki Akasu; Yoshihiro Moriya
Journal:  J Gastrointest Surg       Date:  2009-11-25       Impact factor: 3.452

10.  Rectal and pouch recurrences after surgical treatment for familial adenomatous polyposis.

Authors:  Fabio Guilherme Campos; Antonio Rocco Imperiale; Víctor Edmond Seid; Rodrigo Oliva Perez; Afonso Henrique da Silva e Sousa; Desidério Roberto Kiss; Angelita Habr-Gama; Ivan Cecconello
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.